Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN) -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (124)	3/20/1998 11:17:00 PM
From: Shlepper	Read Replies (2) \| Respond to of 233

Bill, Tom, Thanks for the info. I guess a 6 month (or so) delay justifies the drop in the stock price (and maybe some early outers last week that precipitated this drop). The delay in itself doesn't bother me. The drop in price also doesn't bother me since I'm not selling and am accumulating...but I would like to know what has caused the delay. It seems like quite a long transition from SUCCESSFUL phase 3 results to NDA. They have loads of data, true, but how long should this really take? Have they decided to include the wound healing aspects in the NDA, ie. maximize the NDA application (do I have this right?)? The thing that worries me is that other powerful drugs are working their way into the market, and unexpected delays can shake shareholder confidence. I don't know if this info is related to Zaslof's meeting being cancelled, but I hope and expect that we will get some quick and complete response from the company regarding this issue. Still hanging tough, but with a furrowed brow, Good Luck, Shep